ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Inc (AMPH)

19,74
1,04
(5,56%)
Geschlossen 06 Juni 10:00PM
19,281
-0,459
(-2,33%)
Nach Börsenschluss: 1:56AM

Amphastar Pharmaceuticals Inc (AMPH) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
19,281
( 3,11% )
Gebot
14,57
Fragen
27,56
Volumen
750.319
18,85 Tagesbereich 20,142
16,645 52-Wochen-Bereich 31,2641
Marktkapitalisierung
Handelsende
18,70
Handelsbeginn
18,86
Letzter Handelszeitpunkt
Finanzvolumen
US$ 14.793.283
VWAP
19,716
Durchschnittliches Volumen (3 Mio.)
US$ 621.109
Ausgegebene Aktien
44.092.919
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
11,31
Gewinn pro Aktie (EPS)
1,67
Erlöse (LTM)
720,53M
Nettogewinn (LTM)
79,23M

Über Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of se... Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable form of low molecular weight heparin for the prevention and treatment of deep vein thrombosis; and REXTOVY and Naloxone for opioid overdose. The company also provides Cortrosyn, a lyophilized power for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; and emergency syringe products, including atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate. In addition, it offers Albuterol sulfate inhalation aerosol for the treatment or prevention of bronchospasm; Iron sucrose injection, an iron replacement product for the treatment of iron deficiency anemia in patients with chronic kidney disease; Teriparatide injection for managing daily osteoporosis therapy; and Ipratropium Bromide HFA inhalation aerosol, an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease. Further, the company provides active pharmaceutical ingredient (API) products, such as Recombinant Human Insulin and porcine insulin API. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Hauptsitz
Rancho Cucamonga, United States
Gegründet
1996
Amphastar Pharmaceuticals Inc is listed in the Healthcare sector of the NASDAQ with ticker AMPH. The last closing price for Amphastar Pharmaceuticals was US$18,70. Over the last year, Amphastar Pharmaceuticals shares have traded in a share price range of US$ 16,645 to US$ 31,2641.

Amphastar Pharmaceuticals currently has 44.092.919 shares in issue. The market capitalisation of Amphastar Pharmaceuticals is US$850,16 million. Amphastar Pharmaceuticals has a price to earnings ratio (PE ratio) of 11.31.

AMPH Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0009999999999980.0051867219916919.2819.8517.7363955118.53419851CS
40.2811.478947368421919.8516.64587062218.26163214CS
121.0615.8232711306318.2224.34516.64559560219.54186528CS
26-7.869-28.983425414427.1529.5216.64551120421.98780872CS
52-6.619-25.55598455625.931.264116.64549613523.8139997CS
156-27.419-58.713062098546.767.6616.64547291936.41081616CS
2600.5512.9418045915618.7367.6616.64541124834.80224073CS

AMPH - Frequently Asked Questions (FAQ)

What is the current Amphastar Pharmaceuticals Inc share price?
The current share price of Amphastar Pharmaceuticals Inc is US$ 19,281
How many Amphastar Pharmaceuticals Inc shares are in issue?
Amphastar Pharmaceuticals Inc has 44.092.919 shares in issue
What is the market cap of Amphastar Pharmaceuticals Inc?
The market capitalisation of Amphastar Pharmaceuticals Inc is USD 850,16M
What is the 1 year trading range for Amphastar Pharmaceuticals Inc share price?
Amphastar Pharmaceuticals Inc has traded in the range of US$ 16,645 to US$ 31,2641 during the past year
What is the PE ratio of Amphastar Pharmaceuticals Inc?
The price to earnings ratio of Amphastar Pharmaceuticals Inc is 11,31
What is the cash to sales ratio of Amphastar Pharmaceuticals Inc?
The cash to sales ratio of Amphastar Pharmaceuticals Inc is 1,15
What is the registered address of Amphastar Pharmaceuticals Inc?
The registered address for Amphastar Pharmaceuticals Inc is 11570 6th Street, Rancho Cucamonga, California, 91730
What is the Amphastar Pharmaceuticals Inc website address?
The website address for Amphastar Pharmaceuticals Inc is www.amphastar.com
Which industry sector does Amphastar Pharmaceuticals Inc operate in?
Amphastar Pharmaceuticals Inc operates in the Pharmaceuticals sector

AMPH Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen